Protalix BioTherapeutics (PLX) Gross Profit Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 411.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.16% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 4.34% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 51.16% |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 65.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.77% |
| Dec 31, 2025 | -10.21% |
| Sep 30, 2025 | 10.25% |
| Jun 30, 2025 | 28.01% |
| Mar 31, 2025 | -42.28% |
| Dec 31, 2024 | 38.45% |
| Sep 30, 2024 | 4.70% |
| Jun 30, 2024 | 33.36% |
| Mar 31, 2024 | -44.08% |
| Dec 31, 2023 | -54.00% |
| Sep 30, 2023 | -11.71% |
| Jun 30, 2023 | 46.82% |
| Mar 31, 2023 | -29.07% |
| Dec 31, 2022 | -17.38% |
| Sep 30, 2022 | -13.65% |
| Jun 30, 2022 | -21.24% |
| Mar 31, 2022 | 6.19% |
| Dec 31, 2021 | 131.13% |
| Sep 30, 2021 | 105.35% |
| Jun 30, 2021 | 126.18% |
| Mar 31, 2021 | 59.06% |
| Dec 31, 2020 | 163.51% |
| Sep 30, 2020 | 75.72% |
| Jun 30, 2020 | 122.03% |
| Mar 31, 2020 | 183.34% |
| Dec 31, 2019 | 340.54% |
| Sep 30, 2019 | 196.89% |
| Jun 30, 2019 | 366.65% |
| Mar 31, 2019 | 277.53% |
| Sep 30, 2018 | -46.23% |
| Jun 30, 2018 | -29.25% |
| Mar 31, 2018 | 4.93% |
| Mar 31, 2017 | -37.68% |
| Dec 31, 2016 | 26.41% |
| Sep 30, 2016 | -38.02% |
| Jun 30, 2016 | -62.24% |
| Mar 31, 2016 | -62.66% |
| Sep 30, 2015 | -28.33% |
| Jun 30, 2015 | -63.03% |
| Mar 31, 2015 | -16.34% |
| Mar 31, 2014 | -14.10% |
| Dec 31, 2013 | -58.54% |
| Sep 30, 2013 | -5.79% |
| Jun 30, 2013 | 41.75% |